ATA5972001A - Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form - Google Patents

Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form

Info

Publication number
ATA5972001A
ATA5972001A AT5972001A AT5972001A ATA5972001A AT A5972001 A ATA5972001 A AT A5972001A AT 5972001 A AT5972001 A AT 5972001A AT 5972001 A AT5972001 A AT 5972001A AT A5972001 A ATA5972001 A AT A5972001A
Authority
AT
Austria
Prior art keywords
hydroxyethylides
heptan
azabicyclo
oxa
oxo
Prior art date
Application number
AT5972001A
Other languages
English (en)
Other versions
AT413015B (de
Inventor
Otto Ing Daemon
Herwig Dr Jennewein
Thomas Lentner
Franz Xaver Ing Schwarz
Robert Veigl
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to AT5972001A priority Critical patent/AT413015B/de
Priority to US10/474,480 priority patent/US20040132712A1/en
Priority to EP02740465A priority patent/EP1381362A2/de
Priority to AU2002315287A priority patent/AU2002315287A1/en
Priority to PCT/EP2002/004062 priority patent/WO2002083129A2/en
Publication of ATA5972001A publication Critical patent/ATA5972001A/de
Application granted granted Critical
Publication of AT413015B publication Critical patent/AT413015B/de
Priority to US11/449,041 priority patent/US20060263424A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT5972001A 2001-04-12 2001-04-12 Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form AT413015B (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT5972001A AT413015B (de) 2001-04-12 2001-04-12 Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form
US10/474,480 US20040132712A1 (en) 2001-04-12 2002-04-11 Pharmaceutical compositions comprising clavulanic acid
EP02740465A EP1381362A2 (de) 2001-04-12 2002-04-11 Pharmazeutische zusammensetzung entahaltend clavulansäure
AU2002315287A AU2002315287A1 (en) 2001-04-12 2002-04-11 Pharmaceutical composition comprising clavulanic acid
PCT/EP2002/004062 WO2002083129A2 (en) 2001-04-12 2002-04-11 Pharmaceutical composition comprising clavulanic acid
US11/449,041 US20060263424A1 (en) 2001-04-12 2006-06-07 Pharmaceutical compositions comprising clavulanic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT5972001A AT413015B (de) 2001-04-12 2001-04-12 Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form

Publications (2)

Publication Number Publication Date
ATA5972001A true ATA5972001A (de) 2005-03-15
AT413015B AT413015B (de) 2005-10-15

Family

ID=34222839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT5972001A AT413015B (de) 2001-04-12 2001-04-12 Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form

Country Status (1)

Country Link
AT (1) AT413015B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2733642A1 (de) * 1977-07-26 1979-02-08 Bayer Ag Antibiotische mittel
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
AT413015B (de) 2005-10-15

Similar Documents

Publication Publication Date Title
PL366401A1 (en) Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
IS6150A (is) Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun
DZ3177A1 (fr) Copolymère comprenant l'acide isophtalique.
ZA200210411B (en) Novel heteroaryl derivatives and the use thereof as pharmaceuticals.
ITTO20010861A0 (it) Dispositivo per la conservazione di ossigeno.
ATE303386T1 (de) Das citrat-salz des 5,8,14,- triazatetracyclo(10.3.1.02,11.04,9)-hexadeca- 2(11),3,5,7,9-pentaens
ATE369342T1 (de) 2,5-disubstituierte 3-mercaptopentansaure
ATE263165T1 (de) 3-(4,5-dihydroisoxazol-5-yl)benzoylpyrazole
ITRM20010048A0 (it) Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
ATA5972001A (de) Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form
AU2003236714A8 (en) Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio
ITTO20020794A1 (it) Sitema per controllare le transizioni dalla modalita'
RU2000118409A (ru) Антимутагенное средство
AP2004003005A0 (en) Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives.
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
ES1046317Y (es) Parque recreativo infantil.
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
RU2002107007A (ru) Туберкулостатическое средство
RU2001109481A (ru) Антиангинальное средство
Manning et al. The Human Kinome
Kamil The State of Reading Research
RU99107525A (ru) Противогерпетическое средство
Whitbourne The Revolution Is Coming: Will Psychology Be Ready?
ES1053469Y (es) Parque infantil desmontable.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee